GSK has struck the collaboration to accelerate development of RNA-based therapies for neurodegenerative and renal disorders.

His appointment comes at a pivotal moment for the organisation, as NICE prepares to help deliver the 10 Year Health Plan for the NHS.

Industry leaders cautiously welcome the step but warn that more reform is needed if the UK is to regain its competitive edge.

Last week, the UK and US signed a zero tariff pharmaceuticals deal, but what will the deal deliver in the long term, and is all as it seems?

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on November 2025.

According to the body, patient participation in industry-sponsored trials has fallen by 25% between 2022/23 and 2024/25.

Crucially, 41% of these candidates target pathogens for which no vaccines or prophylactic monoclonal antibodies are currently registered.

A wearable device that can alert patients and caregivers minutes before a seizure occurs is set to launch across Europe.